atril fibrillaiton
Conditions
Interventions
Group 1:Pulmonary vein isolation catheter ablation
Group 2:Pulmonary vein isolation catheter ablation plus linear ablation on the left roof plus or not plus focal ablation outside the pulmonary vein
Sponsors
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Multiple consecutive ecg and Holter tests within 3 months before ablation confirmed full AF; (2) PersAF patients with a duration of more than 7 days and less than 1 year; (3) Aged 18-75 years; (4) Agreed to participate in this study, had understanding ability and signed informed consent, and had good clinical compliance to complete the postoperative clinical follow-up as required by the program.
Exclusion criteria
Exclusion criteria: (1) The diameter of the left atrium >= 50mm; (2) Severe organic heart disease, including moderate to severe valvular insufficiency or stenosis, previous myocardial infarction, and congenital heart disease; (3) Left ventricular ejection fraction < 40%; (4) patients who have undergone coronary artery bypass grafting in the past 3 months or implanted coronary stent within 1 year; (5) NYHA III or IV heart failure; (6) Severe respiratory insufficiency, such as chronic obstructive pulmonary disease, bronchiectasis, and bronchial asthma; (7) patients who have undergone left atrial ablation or surgical treatment for atrial fibrillation; (8) Thrombosis in the left atrium or cloudy echo in the atrium; (9) Known bleeding tendency, or intolerance to heparin or warfarin anticoagulation; (10) Those who participate in other clinical research trials and have not yet reached the main clinical endpoint; (11) Pregnant women; (12) Life expectancy less than 1 year with other serious diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| recurring rate of AF; | — |
Countries
China
Contacts
Public ContactWu Liqun
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Outcome results
None listed